Zobrazeno 1 - 10
of 171
pro vyhledávání: '"L Vahdat"'
Autor:
Heather L. Vahdat, Logan M. Nickels
Publikováno v:
Frontiers in Reproductive Health, Vol 5 (2023)
Multipurpose prevention technologies (MPTs) and male contraceptive methods are currently in development to address unique and critical needs facing the global reproductive health community. Currently, MPT products in development are exclusively femal
Externí odkaz:
https://doaj.org/article/c2995e58937e479181ea90b91520be67
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Biology of Reproduction
Globally, nearly half of all pregnancies are unplanned. Male contraceptives offer the potential to decrease unintended pregnancy and introduce contraceptive equity, but decades of research have yet to bring a novel product to market. New funding aven
Autor:
P.A. Kaufman, C.J. Twelves, A.H. Awada, S-A. Im, L. Vahdat, B. Xu, P. Yuan, W. Hauck, R. Xie, B. Lalayan, J. Cortés
Publikováno v:
Annals of Oncology. 33:S655-S656
Publikováno v:
Biology of Reproduction
Efforts to develop a male contraceptive method beyond condoms and vasectomy have been on-going for nearly 70 years. During this time, there have been ebbs and modest flows of resources available to support product development, but not at a level suff
Publikováno v:
The Journal of Sexual Medicine. 19:S9-S10
Introduction Sexual dysfunction is reported during and after breast cancer treatment and causes a substantial distress on women. Breast cancer and its treatment can cause decreased libido and there are currently no FDA approved medications for the tr
Autor:
Kevin Kalinsky, Javier Cortes, E.C. Gil, Véronique Diéras, Michaela Tsai, Tiffany A. Traina, Lisa A. Carey, L. Vahdat, Florence Dalenc, Philippe Aftimos, Erika Hamilton, Sara A. Hurvitz, Sara M. Tolaney, S. Recalde, L.M. Itri, Priyanka Sharma, Joyce O'Shaughnessy, Hope S. Rugo, Martin Olivo, Mafalda Oliveira, Delphine Loirat, Kevin Punie, Q. Hong, Amelia Zelnak, David M. Goldenberg, Sagar Sardesai, Aditya Bardia
Publikováno v:
Annals of oncology
Scientia
Scientia
Background: The pivotal phase III ASCENT trial demonstrated improved survival outcomes associated with sacituzumab govitecan (SG), an anti-trophoblast cell-surface antigen 2 (anti-Trop-2) antibody-drug conjugate linked with the topoisomerase-inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7674f8ee6f826048de62dac913e752f3
https://lirias.kuleuven.be/handle/20.500.12942/686442
https://lirias.kuleuven.be/handle/20.500.12942/686442
Publikováno v:
Mhealth Innovation ISBN: 9781003192893
Mhealth Innovation
Mhealth Innovation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6626fd725046f42e3d64a95f51d1cc5
https://doi.org/10.4324/9781003192893-35
https://doi.org/10.4324/9781003192893-35
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N. Masuda, S. Hurvitz, L. Vahdat, N. Harbeck, A.C. Wolff, S.M. Tolaney, S. Loi, J. O'Shaughnessy, D. Xie, L. Walker, E. Rustia, V.F. Borges
Publikováno v:
Annals of Oncology. 31:S1267-S1268